Skip to main content

Respiratory Symptoms Occurring 4 Months After Allogeneic Hematopoietic Stem Cell Transplantation

  • Chapter
  • First Online:
Pulmonary Involvement in Patients with Hematological Malignancies

Abstract

Bronchiolitis obliterans (BO) is the most frequent late-onset noninfectious pulmonary complication following an allogeneic hematologic stem cell transplantation attributed to chronic lung graft-versus-host disease. Its management is usually a great challenge when considering both the diagnosis and the treatment. The definite diagnosis relies on histological examination; however, lung biopsies are rarely available. The diagnosis must then be retained for converging arguments based on clinical and radiological features and pulmonary function testing. However, clinical, radiological and functional characteristics of patients with BO may be various, leading to difficulties in diagnosis. Furthermore, the treatment of BO is currently a controversial issue, and its evaluation is limited by not knowing the natural history. Herein, through a demonstrative case study, we discuss the diagnostic and therapeutic approach for a patient with a biopsy-proven BO following allogeneic stem cell transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Afessa B, Peters SG (2005) Chronic lung disease after hematopoietic stem cell transplantation. Clin Chest Med 26: 571–586, vi

    Article  PubMed  Google Scholar 

  2. Bashoura L, Gupta S, Jain A et al (2008) Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 41: 63–67

    Article  PubMed  CAS  Google Scholar 

  3. Bergeron A, Belle A, Chevret S et al (2007) Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 39:547–553

    Article  PubMed  CAS  Google Scholar 

  4. Chan CK, Hyland RH, Hutcheon MA et al (1987) Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) 66:327–340

    CAS  Google Scholar 

  5. Clark JG, Crawford SW, Madtes DK et al (1989) Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 111: 368–376

    PubMed  CAS  Google Scholar 

  6. Dudek AZ, Mahaseth H, DeFor TE et al (2003) Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 9:657–666

    Article  PubMed  Google Scholar 

  7. Erard V, Chien JW, Kim HW et al (2006) Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis 193:1619–1625

    Article  PubMed  Google Scholar 

  8. Filipovich AH, Weisdorf D, Pavletic S et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945–956

    Article  PubMed  Google Scholar 

  9. Franquet T, Muller NL (2003) Disorders of the small airways: high-resolution computed tomographic features. Semin Respir Crit Care Med 24:437–444

    Article  PubMed  Google Scholar 

  10. Gerhardt SG, McDyer JF, Girgis RE et al (2003) Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 168: 121–125

    Article  PubMed  Google Scholar 

  11. Gulbahce HE, Baker KS, Kumar P et al (2003) Atypical cells in bronchoalveolar lavage specimens from bone marrow transplant recipients. A potential pitfall. Am J Clin Pathol 120:101–106

    Article  PubMed  Google Scholar 

  12. Gunn ML, Godwin JD, Kanne JP et al (2008) High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging 23:244–250

    Article  PubMed  Google Scholar 

  13. Hallstrand TS, Sprenger JD, Agosti JM et al (2004) Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors. Blood 104:3086–3090

    Article  PubMed  CAS  Google Scholar 

  14. Khalid M, Al Saghir A, Saleemi S et al (2005) Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 25:490–493

    Article  PubMed  CAS  Google Scholar 

  15. Maimon N, Lipton JH, Chan CK et al (2009) Macrolides in the treatment of bronchiolitis obliterans in allograft recipients. Bone Marrow Transplant 44:69–73

    Article  PubMed  CAS  Google Scholar 

  16. Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968

    Article  PubMed  CAS  Google Scholar 

  17. Philit F, Wiesendanger T, Archimbaud E et al (1995) Post-transplant obstructive lung disease (“bronchiolitis obliterans”): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 8:551–558

    PubMed  CAS  Google Scholar 

  18. Rochat I, Posfay-Barbe KM, Kumar N et al (2008) Bronchoalveolar cytology for diagnosing pulmonary GVHD after bone marrow transplant in children. Pediatr Pulmonol 43:697–702

    Article  PubMed  CAS  Google Scholar 

  19. Santo Tomas LH, Loberiza FR Jr, Klein JP et al (2005) Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 128: 153–161

    Article  PubMed  Google Scholar 

  20. Sargent MA, Cairns RA, Murdoch MJ et al (1995) Obstructive lung disease in children after allogeneic bone marrow transplantation: evaluation with high-resolution CT. AJR Am J Roentgenol 164:693–696

    PubMed  CAS  Google Scholar 

  21. St John RC, Gadek JE, Tutschka PJ et al (1990) Analysis of airflow obstruction by bronchoalveolar lavage following bone marrow transplantation. Implications for pathogenesis and treatment. Chest 98:600–607

    Article  PubMed  CAS  Google Scholar 

  22. White DA, Wong PW, Downey R (2000) The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 161:723–729

    PubMed  CAS  Google Scholar 

  23. Williams KM, Chien JW, Gladwin MT et al (2009) Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 302:306–314

    Article  PubMed  CAS  Google Scholar 

  24. Yousem SA (1995) The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 26:668–675

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne Bergeron .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bergeron, A., Feuillet, S., Meignin, V., Ribaud, P., Tazi, A. (2011). Respiratory Symptoms Occurring 4 Months After Allogeneic Hematopoietic Stem Cell Transplantation. In: Azoulay, E. (eds) Pulmonary Involvement in Patients with Hematological Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15742-4_58

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-15742-4_58

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-15741-7

  • Online ISBN: 978-3-642-15742-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics